Amgen Inc.Equity-NMS: AMGN
Equity-NMS: AMGN
$238.03
+4.92
(24 Mar)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$238.03
Open
$238.03
52W high
$296.67
1Y
2.85%
5Y
10.26%
PE
19.00
Div yield
3.37%
EPS (TTM)
12.11
Dividend
7.86
Shares O/S
533.98M
Market cap
127.1B
Insights
AMGN price is above its 200 day moving average
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Amgen Inc.

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine).

It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma. .


FAQs

Can I buy Amgen Inc. shares in India?
How to buy Amgen Inc. shares in India?
What is the share price of Amgen Inc.?
What is the Market Capitalization of Amgen Inc.?
What is the PE ratio of Amgen Inc.?
Is Amgen Inc. a good stock to buy?
In which sector / industry does Amgen Inc. operate?